Abstract
Background: Concomitant use of several medications for somatic and mental disorders is common in elderly people and increases the risk of falls, with hip fracture being the most serious consequence.
Objective: The objective of this study was to describe relationships between use of sedatives, antipsychotics or potent anticholinergics and postoperative mortality in patients with hip fractures.
Methods: A retrospective analysis was conducted on population-based data collected during a 2-year period from 1999 to 2000 on 461 hip fracture surgery patients aged ≥65 years in Finland. Information on co-morbidities and intake of sedatives, antipsychotics and potent anticholinergics was obtained from the original patient records. Information on deaths was obtained from the official death statistics in Finland.
Results: In men, use of potent anticholinergics was associated with excess age-adjusted mortality at 30 days, 3 months, 6 months and 3 years, but not in women at any timepoint. Use of potent anticholinergic drugs emerged as an independent predictor of excess mortality in men at 3 months and 3 years. Presence of cardiovascular disease and chronic lung disease were independent risk factors for excess mortality at 6 months and 3 years in men. In addition, chronic lung disease independently predicted excess mortality at 30 days.
Conclusion: Use of potent anticholinergics should be evaluated critically after diseases.
Similar content being viewed by others
References
Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319(26): 1701–7
Lyritis GP. Epidemiology of hip fracture: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int 1996; 6Suppl. 3: 11–5
Paksima N, Koval KJ, Aharanoff G, et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis 2008; 66(2): 111–7
Giron MS, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001; 49(3): 277–83
Pomara N, Stanley B, Block R, et al. Increased sensitivity of the elderly to the central depressant effects of diazepam. J Clin Psychiatry 1985; 46(5): 185–7
Meador KJ. Cognitive side effects of medications. Neurol Clin 1998; 16(1): 141–55
Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry 2007; 190: 129–34
Allain H, Bentue-Ferrer D, Polard E, et al. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005; 22(9): 749–65
Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001; 62Suppl. 21: 11–4
French DD, Campbell R, Spehar A, et al. Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging 2005; 22(10): 877–85
Statistics Finland [online]. Available from URL: http://www.tilastokeskus.fi [Accessed 2008 Dec 21]
World Health Organization. Tautiluokitus ICD-10 (Classification of Diseases ICD-10). Rauma: Kirjapaino Oy West Point, 1995
National Agency of Medicines. Classification of medicines (ATC) and defined daily doses (DDD) 2004. Helsinki: National Agency of Medicines, 2004
Pollock BG. Psychotropic drugs and the aging patient. Geriatrics 1998; 53Suppl. 1: S20–4
Kay GG, Abou-Donia MB, Messer WS, et al. Anti-muscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005; 53(12): 2195–201
Wehren LE, Hawkes WG, Orwig DL, et al. Gender differences in mortality after hip fracture: the role of infection. J Bone Miner Res 2003; 18(12): 2231–7
Poor G, Atkinson EJ, O’Fallon WM, et al. Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res 1995; (319): 260–5
Singh S, Loke YK, Furberg CD. Inhaled anticholiner-gics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300(12): 1439–50
Herrmann N, Lanctot KL. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned? Drug Saf 2006; 29(10): 833–43
Laaksonen M, Uutela A, Vartiainen E, et al. Development of smoking by birth cohort in the adult population in eastern Finland 1972-97. Tob Control 1999; 8(2): 161–8
Hartikainen S, Ahto M, Lopponen M, et al. Change in the prevalence of coronary heart disease among Finnish elderly men and women in the 1990s. Scand J Prim Health Care 2003; 21(3): 178–81
Mattila VM, Sillanpaa P, Iivonen T, et al. Coverage and accuracy of diagnosis of cruciate ligament injury in the Finnish National Hospital Discharge Register. Injury 2008; 39(12): 1373–6
Holmes JD, House AO. Psychiatric illness in hip fracture. Age Aging 2000; 29(6): 537–46
Hosia-Randell H, Pitkala K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 2005; 22(9): 793–800
Puustinen J, Nurminen J, Kukola M, et al. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Drugs Aging 2007; 24(12): 1045–59
Schor JD, Levkoff SE, Lipsitz LA, et al. Risk factors for delirium in hospitalized elderly. JAMA 1992; 267(6): 827–31
Berggren D, Gustafson Y, Eriksson B, et al. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg 1987; 66(6): 497–504
Magaziner J, Simonsick EM, Kashner TM, et al. Survival experience of aged hip fracture patients. Am J Public Health 1989; 79(3): 274–8
Bass E, French DD, Bradham DD, et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 2007; 17(7): 514–9
French DD, Bass E, Bradham DD, et al. Rehospitalization after hip fracture: predictors and prognosis from a national veterans study. J Am Geriatr Soc 2008; 56(4): 705–10
Acknowledgements
This study was supported by a Satakunta Hospital District EVO-grant. The financial sponsor had no role in the design and conduct of the study or in the preparation, review and approval of the manuscript.
The authors have no conflicts of interest that are directly relevant to the content of this study.
The authors wish to thank Virginia Mattila, University of Tampere, Finland, for editing the language and Jukka Saukkoriipi for technical assistance in biostatistics.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Panula, J., Puustinen, J., Jaatinen, P. et al. Effects of Potent Anticholinergics, Sedatives and Antipsychotics on Postoperative Mortality in Elderly Patients with Hip Fracture. Drugs Aging 26, 963–971 (2009). https://doi.org/10.2165/11317660-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11317660-000000000-00000